Articles

Canteen is excited to launch our newest product range made in partnership with Dannii Minogue and Canteen youth ambassadors Nate, Jupiter, Emily and Franki.

In July 2024, young people from the Youth Cancer Services (YCS) State Youth Advisory Groups met in Sydney for the Annual National Youth Cancer Consumer Forum.

Delta Goodrem recently joined Canteen for a screening of her movie, Love is in the Air, with key members of Melbourne’s philanthropic and corporate community to raise awareness and funds for Canteen.

Canteen is urging the Federal Government to allocate $11.9 million for a pioneering project to research the full extent of youth cancer.

Canteen are pleased to announce that we are the beneficiaries of an $80,000 commitment from The Lottery Office, which will allow more young people in the NT to have dedicated counselling support.

The Living with Cancer resource is now available in six additional languages, making this resource in cancer navigation more accessible for people from culturally and linguistically diverse backgrounds

Canteen is proud to share the final report from our Innovate Reconciliation Action Plan (RAP), marking the next step in our reconciliation journey.

After 13 years of dedicated service and unwavering commitment to young Australians impacted by cancer, Canteen’s CEO Peter Orchard has announced he will step down in July 2025.

2024 was a big year at Canteen - read about all the highlights from the range of programs and events that went down!

December 2024 saw the AYA Global Cancer Congress take place in Melbourne, which saw people fly in from around Australia and the world for four packed days of workshops, exhibitions and presentations. Read about what took place!

Watch the music video made in collaboration between young cancer patients and Luke Escombe about the challenges that cancer brings to young lives.

A critical gap in Australia’s cancer care system is leaving adolescents and young adults (AYAs) with cancer aged 19-25 without access to potentially life-saving personalised medicine.